Use of murine poxvirus for cancer immunotherapy and vaccines
The present invention provides a murine poxvirus vector for expressing a heterologous sequence under the control of a viral early/late promoter, and methods for their use in immunotherapy, cancer treatment, and infectious disease treatment. 本发明提供了一种用于在病毒早期/晚期启动子的控制下表达异源序列的鼠痘病毒载体,以及其用于免疫疗法、癌症治疗和传染病治疗...
Gespeichert in:
Hauptverfasser: | , , , |
---|---|
Format: | Patent |
Sprache: | chi ; eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The present invention provides a murine poxvirus vector for expressing a heterologous sequence under the control of a viral early/late promoter, and methods for their use in immunotherapy, cancer treatment, and infectious disease treatment.
本发明提供了一种用于在病毒早期/晚期启动子的控制下表达异源序列的鼠痘病毒载体,以及其用于免疫疗法、癌症治疗和传染病治疗的方法。 |
---|